Inositol Treatment and ART Outcomes in Women with PCOS

about

The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.

P2860

Q47928353-8DD9142D-4F7C-4558-85C4-BA267609862E

P2860

Inositol Treatment and ART Outcomes in Women with PCOS

Item

http://www.wikidata.org/entity/Q28077261

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Inositol Treatment and ART Outcomes in Women with PCOS

@ast

Inositol Treatment and ART Outcomes in Women with PCOS

@en

Inositol Treatment and ART Outcomes in Women with PCOS

@nl

type

Item

label

Inositol Treatment and ART Outcomes in Women with PCOS

@ast

Inositol Treatment and ART Outcomes in Women with PCOS

@en

Inositol Treatment and ART Outcomes in Women with PCOS

@nl

prefLabel

Inositol Treatment and ART Outcomes in Women with PCOS

@ast

Inositol Treatment and ART Outcomes in Women with PCOS

@en

Inositol Treatment and ART Outcomes in Women with PCOS

@nl

P1476

Inositol Treatment and ART Outcomes in Women with PCOS

@en

P2093

Deepika Garg

http://www.w3.org/2001/XMLSchema#string

P2860

D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance

Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome

Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome

A stereospecific myo-inositol/D-chiro-inositol transporter in HepG2 liver cells. Identification with D-chiro-[3-3H]inositol

In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.

chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects

P304

1979654

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3145483

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/1979654

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Reshef Tal

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27795706

http://www.w3.org/2001/XMLSchema#string

P932

5067314

http://www.w3.org/2001/XMLSchema#string

Inositol Treatment and ART Outcomes in Women with PCOS

about

P2860

P2860

Inositol Treatment and ART Outcomes in Women with PCOS

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P478

P50

P577

P698

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P478

P50

P577

P698

P932